Long COVID Prevalence in U.S. Military and Veteran Populations: Corrected National Estimates Using US-CCUC Military™
- 5 days ago
- 38 min read
Updated: 1 day ago
A CYNAERA Institute White Paper on Military Epidemiology, Healthcare Planning, and Population Health Intelligence
This paper is part of the CYNAERA Long COVID Library, a growing resource, impacting how infection associated chronic conditions are treated and understood.
By Cynthia Adinig
1. Executive Summary
US-CCUC Military™ estimates that 3.5 to 5.3 million U.S. veterans are living with Long COVID (Adinig, 2026). This corrected national estimate represents the first US-CCUC™ application developed specifically for U.S. military and veteran populations and provides a more realistic planning population than diagnosis-based surveillance alone. Long COVID has become one of the defining health challenges of the post-pandemic era, yet its impact on America's veteran community remains substantially underestimated. Current federal tracking primarily relies on administrative diagnosis codes, specialty clinic enrollment, and healthcare utilization, each measuring only part of the overall population living with Long COVID. As a result, national planning for veteran healthcare, disability systems, workforce participation, rehabilitation services, and military readiness is likely based on incomplete population estimates (CDC, 2024; National Academies of Sciences, Engineering, and Medicine, 2024).
Existing Veterans Affairs research demonstrates the magnitude of this gap. A national VA analysis found that only 5.28% of veterans with documented SARS-CoV-2 infection received an ICD-10 U09.9 diagnosis for Long COVID within twelve months, while also identifying substantial regional and facility-level differences in diagnostic documentation (Wander et al., 2023). Applied to the current U.S. veteran population of 16.96 million adults, this administrative surveillance represents approximately 896,000 documented veterans (U.S. Bureau of Labor Statistics, 2026).
Other surveillance approaches identify dramatically different populations. A Veterans Affairs Long COVID clinic study identified only 0.6% of veterans through specialty clinical follow-up, with investigators concluding that Long COVID was likely underdiagnosed within their cohort (Elfessi et al., 2025). Conversely, a large symptom-based VA study identified persistent post-COVID symptoms in 45% of COVID-positive veterans, demonstrating that substantially larger affected populations exist beyond administrative diagnosis alone (Stephens et al., 2024).
US-CCUC Military™ reconciles these findings by recognizing that they are not competing prevalence estimates. They represent different levels of case recognition within the healthcare system. Building upon the previously published US-CCUC™ framework, CYNAERA integrates published epidemiologic evidence, documented surveillance limitations, and veteran-specific exposure characteristics to produce a corrected national estimate that more accurately reflects the number of veterans living with Long COVID (Adinig, 2026). The implications extend far beyond epidemiology. More accurate prevalence estimates directly influence Veterans Affairs capacity planning, disability forecasting, rehabilitation services, caregiver support, workforce participation, military readiness, federal budgeting, and future pandemic preparedness. Counting people accurately is not simply a research objective. It is the foundation for effective policy, healthcare planning, and national preparedness.
Key Findings
Estimated veterans living with Long COVID: 3.5–5.3 million
Estimated annual economic impact: $20–30 billion
Estimated additional outpatient visits annually: 17.9–27.1 million
Estimated five-year excess healthcare costs: $24.9–37.8 billion
Veterans potentially experiencing employment disruption: 700,000–1.06 million
2. Introduction
Long COVID has emerged as one of the most significant chronic health consequences of the COVID-19 pandemic, affecting millions of individuals long after resolution of the initial infection. While considerable progress has been made in characterizing the biological mechanisms underlying post-COVID illness, far less attention has been devoted to accurately estimating the size of the populations living with its long-term effects. Existing surveillance approaches often rely on administrative diagnosis codes, specialty clinic enrollment, or narrowly defined research cohorts, each capturing only a portion of the overall population. As a result, prevalence estimates frequently vary by several-fold depending on how cases are identified rather than reflecting meaningful differences in disease biology (CDC, 2024; National Academies of Sciences, Engineering, and Medicine [NASEM], 2024; Davis et al., 2023; Peluso et al., 2023).
This challenge is particularly important within U.S. military and veteran populations. Military service members and veterans represent one of the most extensively monitored healthcare populations in the world, yet they also experience a unique combination of occupational, environmental, and infectious exposures that distinguish them from the general U.S. population. Throughout military service, personnel routinely encounter close quarter living environments, international travel, deployments, demanding operational tempos, environmental extremes, repeated respiratory pathogen exposure, and occupational stressors that influence both acute infectious disease risk and long-term health outcomes. One of the most recent examples, is the flu outbreak that sickened 200 trainees at Lackland Air Force Base. However, following separation from active service, many veterans continue to experience elevated healthcare utilization, chronic medical conditions, and employment within public facing occupations, creating additional opportunities for both infectious exposure and clinical recognition (Adams et al., 2021; Al-Aly et al., 2022; Schawaller et al., 2021).
Military medicine has long recognized that protecting force readiness requires more than treating illness after it occurs. Over the past century, the Department of Defense has invested heavily in infectious disease surveillance, environmental health, preventive medicine, nutritional science, occupational health, and deployment medicine to identify health threats before they compromise operational capability. This systems-oriented philosophy has produced one of the world's most sophisticated military surveillance infrastructures, incorporating the Defense Medical Surveillance System (DMSS), the Armed Forces Health Surveillance Division (AFHSD), the Disease Reporting System internet (DRSi), the Medical Surveillance Monthly Report (MSMR), and numerous condition-specific monitoring programs. These systems acknowledge an important reality: understanding population health requires looking beyond individual diagnoses to identify broader patterns across the force.
Long COVID presents a natural extension of this philosophy. Persistent post-infectious illness has direct implications for physical performance, cognitive function, cardiopulmonary capacity, autonomic regulation, rehabilitation, deployability, workforce participation, disability planning, and long-term healthcare utilization. Even relatively modest underestimation of prevalence can substantially influence Veterans Affairs resource allocation, specialty clinic capacity, caregiver support, workforce projections, and future federal preparedness strategies. Accurate prevalence estimation is therefore not simply an epidemiologic exercise. It is a planning imperative.
Recent developments have further elevated the urgency of this issue. Long COVID continues to receive increasing attention across federal agencies, including the Department of Health and Human Services, the National Institutes of Health, the Department of Veterans Affairs, and the National Academies of Sciences, Engineering, and Medicine. At the same time, military medicine has renewed public discussion surrounding respiratory disease preparedness, force health protection, vaccination policy, and operational readiness. Together, these developments create an opportunity to revisit one of the most fundamental questions facing military and veteran healthcare: How many veterans are actually living with Long COVID?
Existing studies provide important but incomplete answers. Administrative analyses, specialty clinic cohorts, and symptom-based investigations each capture different segments of the veteran population, producing estimates that range from less than one percent to nearly one-half of previously infected veterans (Wander et al., 2023; Stephens et al., 2024; Elfessi et al., 2025). Rather than viewing these findings as contradictory, this paper argues that they represent different levels of clinical visibility within the healthcare system. The challenge is not determining which estimate is correct. The challenge is determining how these observations fit together to produce a realistic national estimate.
To address this gap, this paper introduces US-CCUC Military™, an extension of CYNAERA's previously developed 2026 U.S. Chronic Condition Undercount Correction (US-CCUC™) framework. Building upon published epidemiologic evidence, military health surveillance principles, and veteran-specific exposure characteristics, US-CCUC Military™ generates a corrected national estimate of Long COVID prevalence designed to better support healthcare planning, disability forecasting, military readiness assessments, and future federal decision-making. Rather than replacing existing surveillance systems, the framework complements them by estimating the population that exists beyond administrative diagnosis alone. Ultimately, the objective of this paper is straightforward. It is not to redefine Long COVID or propose a new case definition. It is to improve how the United States estimates the number of veterans living with Long COVID so that healthcare planning, policy development, and resource allocation more closely reflect the population already present within the veteran community.
3. The Military as a Living Health System
The United States military represents one of the most sophisticated population health surveillance systems in the world. Unlike most civilian healthcare systems, which primarily respond to illness after individuals seek medical care, military medicine has evolved around continuous surveillance, prevention, environmental monitoring, force readiness, and early intervention. Operational success depends not only on treating disease but on anticipating health threats before they compromise individual service members or the readiness of an entire force. Consequently, the Department of Defense has spent decades developing an integrated surveillance infrastructure that continuously monitors infectious diseases, environmental exposures, occupational hazards, nutrition, vaccination, deployment health, injury patterns, and emerging biological threats (Rubertone & Brundage, 2002; Chretien et al., 2007; Armed Forces Health Surveillance Division, 2025; Allman et al., 2026).
This surveillance philosophy extends across multiple complementary systems. The Defense Medical Surveillance System (DMSS) maintains longitudinal health records for millions of service members, while the Disease Reporting System internet (DRSi) captures reportable medical events considered important to military public health and operational readiness. The Armed Forces Health Surveillance Division (AFHSD) and the Medical Surveillance Monthly Report (MSMR) routinely analyze infectious disease trends, respiratory illness, vector-borne disease, sexually transmitted infections, heat illness, exertional rhabdomyolysis, deployment-related conditions, vaccination outcomes, and environmental health risks to identify emerging threats before they affect military operations (Armed Forces Reportable Medical Events Guidelines, 2022; Allman et al., 2026; AFHSD, 2025).
Importantly, military surveillance has never been limited to identifying acute illness. The military has long recognized that seemingly unrelated biological, environmental, and occupational factors interact to influence long-term health and operational performance. Heat stress, sleep disruption, nutritional deficiencies, environmental particulate exposure, altitude, infectious disease, psychological stress, repetitive physical demands, and occupational toxicants are routinely investigated because each has the potential to influence readiness at both the individual and population level (Institute of Medicine, 2008; National Academies of Sciences, Engineering, and Medicine, 2019; AFHSD, 2025).
This systems perspective is particularly evident in deployment medicine. Military deployments expose personnel to diverse infectious pathogens, changing climates, altered diets, variable air quality, vector-borne diseases, occupational hazards, and unfamiliar environmental conditions that differ substantially from civilian life. Schawaller and colleagues documented imported malaria, schistosomiasis, giardiasis, tuberculosis, strongyloidiasis, leishmaniasis, and other infections among German military personnel returning from tropical deployments, noting that many infections presented with atypical or absent symptoms despite laboratory confirmation.
The authors concluded that systematic post-deployment screening remained essential because clinical presentation alone failed to identify the true scope of deployment-associated infectious disease (Schawaller et al., 2021). Similar surveillance principles have guided U.S. military preventive medicine for decades through deployment health assessments, infectious disease monitoring, and environmental exposure surveillance (Chretien et al., 2007; AFHSD, 2025).
Environmental health has likewise become an increasingly important component of military medicine. Vitamin D deficiency illustrates how operational environments influence biological resilience beyond traditional disease models. Military studies have demonstrated that deficiency varies according to occupation, season, latitude, race, body composition, and time spent indoors, while broader biomedical research has linked inadequate vitamin D status to musculoskeletal injury, impaired immune regulation, autoimmune disease, cardiovascular disease, neurocognitive dysfunction, infectious disease susceptibility, and overall mortality (Holick, 2007; Pludowski et al., 2013; Pilz et al., 2019; Rossi et al., 2026). Rather than viewing vitamin D solely as a nutritional issue, military medicine increasingly recognizes it as one component of a broader systems model in which environmental conditions interact with immune function, physical performance, and long-term health outcomes.
This broader philosophy reflects an important characteristic of military medicine: health is understood as the product of interacting biological and environmental systems rather than isolated diagnoses. Infectious disease surveillance, preventive medicine, occupational health, deployment medicine, environmental monitoring, nutrition, sleep science, exercise physiology, and behavioral health collectively contribute to maintaining operational readiness. Modern systems biology and precision medicine increasingly support this perspective, recognizing that disease often emerges from the cumulative interaction of multiple physiological and environmental influences rather than a single pathogenic event (Hood & Flores, 2012; National Research Council, 2011; Loscalzo & Barabási, 2011).
Long COVID naturally fits within this systems-oriented framework. Service members experience repeated respiratory pathogen exposure, congregate living environments, international travel, variable air quality, environmental stressors, physically demanding occupations, disrupted sleep, frequent vaccination programs, and continual healthcare surveillance throughout military service. Many veterans continue to encounter elevated healthcare utilization, chronic disease, disability, and public-facing occupations following separation from active duty. Collectively, these experiences distinguish military and veteran populations from average-risk civilian populations and suggest that conventional prevalence models may not fully capture the long-term consequences of SARS-CoV-2 infection.
US-CCUC Military™ builds upon this long standing military philosophy. Rather than treating Long COVID as an isolated post-viral diagnosis, the framework recognizes military and veteran populations as high exposure, high stacking populations whose cumulative infectious, environmental, occupational, and physiological experiences influence both the development and recognition of persistent illness. In doing so, US-CCUC Military™ extends the systems based principles already embedded within military preventive medicine toward a corrected national estimate of Long COVID in U.S. veterans.
4. Current Evidence on Long COVID in Military and Veteran Populations
Long COVID is now recognized as one of the most significant long-term consequences of SARS-CoV-2 infection, affecting multiple organ systems and producing persistent symptoms that extend well beyond the acute viral phase. Although considerable uncertainty remains regarding pathophysiology, there is broad scientific consensus that Long COVID represents a heterogeneous condition characterized by persistent fatigue, post-exertional symptom exacerbation, cognitive dysfunction, autonomic impairment, cardiopulmonary abnormalities, sleep disturbance, pain, gastrointestinal dysfunction, immune dysregulation, and reduced functional capacity (WHO, 2021; CDC, 2024; NASEM, 2024; Davis et al., 2023; Peluso et al., 2023; Komaroff & Lipkin, 2023; Phetsouphanh et al., 2022; Putrino et al., 2023).
Military populations have become central to Long COVID research because they offer one of the largest integrated healthcare datasets available worldwide. Unlike fragmented civilian healthcare systems, the Military Health System and the Veterans Health Administration enable investigators to evaluate millions of individuals across standardized electronic health records, longitudinal follow-up, occupational histories, vaccination records, deployment experiences, and healthcare utilization. As a result, some of the largest epidemiologic studies examining Long COVID, cardiovascular complications, neurological sequelae, metabolic disease, and long-term mortality have emerged from military and veteran populations (Al-Aly et al., 2022; Xie et al., 2022; Wander et al., 2023; Stephens et al., 2024).
Early military literature focused primarily on operational readiness rather than prevalence. Adams and colleagues argued that persistent post-COVID symptoms had implications for deployability, aviation medicine, diving medicine, special operations, and return-to-duty decisions, emphasizing that military medicine would require longitudinal approaches to understand the lasting effects of SARS-CoV-2 infection (Adams et al., 2021). More recently, the Defense Health Agency identified Long COVID as an emerging readiness concern, demonstrating that predictive modeling could identify service members at elevated risk for future Long COVID diagnoses up to six months before clinical recognition. Internal Military Health System data further suggested that as many as one in five service members experienced persistent post-COVID symptoms, highlighting the potential operational consequences of prolonged illness even within relatively young and healthy military populations (Bova et al., 2025).
Subsequent symptom-based investigations identified even larger affected populations. An electronic cohort study involving more than 600,000 active-duty service members found that approximately 42% experienced at least one persistent symptom beyond thirty days following acute COVID-19 infection. Pulmonary, neurological, fatigue-related, gastrointestinal, and constitutional symptoms were among the most frequently reported manifestations, demonstrating that post-COVID illness extended well beyond respiratory disease alone. Importantly, the authors noted that prevalence varied substantially depending upon the symptom definition and observation period employed, reinforcing the importance of surveillance methodology when estimating Long COVID populations (Cintron et al., 2026).
Veterans Affairs investigations demonstrate a remarkably similar pattern while simultaneously illustrating why prevalence estimates differ so substantially across the literature. Wander and colleagues evaluated 388,980 veterans with laboratory-confirmed SARS-CoV-2 infection following introduction of ICD-10 code U09.9. Using administrative diagnosis codes, cumulative documentation reached 4.79% at six months and 5.28% at twelve months after infection.
However, the investigators also identified significant regional and facility-level variation in coding practices, concluding that administrative documentation reflected local recognition and documentation patterns in addition to underlying disease frequency (Wander et al., 2023).
An even smaller population emerged from specialty clinical surveillance. Elfessi and colleagues reviewed more than 3,200 elderly, high-risk veterans receiving care through the Jesse Brown VA Medical Center and identified only 20 veterans, representing approximately 0.6% of the cohort, who were diagnosed with Long COVID and followed within the institution's dedicated Long COVID clinic. Rather than interpreting this finding as evidence that Long COVID was uncommon, the investigators concluded that the condition was likely underdiagnosed within their veteran population and emphasized the need for improved clinical recognition (Elfessi et al., 2025).
In contrast, Stephens and colleagues approached the problem from an entirely different perspective. Instead of relying on administrative diagnosis, the investigators evaluated 363,825 COVID-positive veterans using a symptom-defined Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) framework. Their analysis identified persistent post-COVID symptoms in 164,315 veterans, representing approximately 45% of the study population between 30 and 180 days after infection. The authors specifically observed that ICD-10-based surveillance alone fails to identify many veterans experiencing persistent symptom clusters without formal diagnostic labeling, resulting in substantial underascertainment when administrative coding is used as the primary measure of prevalence (Stephens et al., 2024).
These observations closely parallel findings from the broader Long COVID literature. The NIH RECOVER Initiative, CDC surveillance programs, the Yale LISTEN Study, the PolyBio Research Foundation, Mount Sinai's Cohen Center for Recovery from Complex Chronic Illness, and multiple international cohort studies consistently demonstrate that prevalence estimates vary according to case definition, duration of follow-up, symptom ascertainment, healthcare access, and surveillance methodology rather than reflecting fundamentally different biological diseases (RECOVER Initiative, 2024; CDC, 2024; Davis et al., 2023; Peluso et al., 2023; Putrino et al., 2023; Al-Aly et al., 2022; WHO, 2021).
Importantly, these studies should not be interpreted as competing estimates. Instead, they appear to describe different levels of clinical visibility. Specialty clinics identify the most recognized and often most severely affected patients. Administrative diagnosis captures individuals who receive formal coding within routine healthcare. Symptom-based investigations identify a substantially larger population whose post-COVID illness becomes visible when researchers evaluate persistent symptoms directly rather than relying on diagnostic labels alone. Together, these findings suggest that the apparent disagreement within the literature reflects differences in surveillance methodology rather than disagreement regarding the existence or significance of Long COVID in military and veteran populations.
Representative Long COVID Studies in Military and Veteran Populations
Study | Population | Surveillance Method | Estimated Prevalence | Principal Finding |
Adams et al., 2021 | Active-duty military | Clinical review | N/A | Long COVID presents important implications for operational readiness, return-to-duty decisions, and military medicine. |
Bova et al., 2025 | 464,356 active-duty personnel | Predictive surveillance modeling | Up to 20% internal estimate | Long COVID affects readiness and can be forecast using military health data. |
Cintron et al., 2026 | >600,000 active-duty personnel | Symptom-based surveillance | 42% | Persistent symptoms are common when active surveillance extends beyond diagnostic coding. |
Wander et al., 2023 | 388,980 veterans | ICD-10 U09.9 documentation | 5.28% | Administrative coding varies substantially across VA facilities. |
Elfessi et al., 2025 | 3,286 veterans | Specialty Long COVID clinic | 0.6% | Investigators concluded Long COVID was likely underdiagnosed. |
Stephens et al., 2024 | 363,825 veterans | Symptom-defined PASC | 45% | Symptom surveillance identified a substantially larger population than diagnosis-based methods. |
The convergence between the 42% active-duty symptom estimate and the 45% symptom-defined veteran estimate represents one of the most important observations in the current literature. Independent investigations conducted in distinct military populations reached remarkably similar conclusions when persistent symptoms, rather than diagnostic codes, served as the primary surveillance method. Conversely, studies relying primarily upon administrative documentation or specialty clinic enrollment consistently identified substantially smaller populations. These findings collectively establish the central premise of US-CCUC Military™: how Long COVID is measured fundamentally determines how many people are counted.
5. US-CCUC Military™: Correcting Long COVID Prevalence in U.S. Veterans
Despite rapidly expanding research on Long COVID, the published literature continues to report remarkably different prevalence estimates among military and veteran populations. Depending upon study design, investigators have estimated that fewer than one percent of veterans have Long COVID, while other studies suggest persistent post-COVID symptoms affect nearly one-half of infected veterans (Elfessi et al., 2025; Wander et al., 2023; Stephens et al., 2024; Cintron et al., 2026). At face value these findings appear contradictory. However, closer examination suggests they are measuring different stages of disease recognition rather than different diseases.
Specialty Long COVID clinics primarily capture veterans who have successfully navigated referral pathways and received comprehensive evaluation. Administrative ICD-10 surveillance measures veterans whose illness has been formally recognized and coded within electronic health records. Symptom-based investigations identify veterans experiencing persistent post-COVID illness regardless of whether a formal diagnosis has been assigned. Each surveillance strategy therefore measures a different layer of visibility within the same underlying population.
US-CCUC Military™ was developed to reconcile these differences by applying CYNAERA's broader U.S. Chronic Condition Undercount Correction (US-CCUC™) framework to military and veteran populations (Adinig, 2026). Rather than selecting one prevalence estimate as "correct," the framework integrates multiple surveillance approaches to estimate the most plausible national planning population living with Long COVID.
Military populations warrant dedicated modeling because they differ substantially from the general U.S. population. Active-duty service members and veterans experience repeated respiratory pathogen exposure, congregate living environments, operational stress, deployment-related environmental hazards, disrupted sleep, climate variability, occupational particulate exposure, vaccination programs, physically demanding work, and frequent geographic relocation. Many veterans subsequently transition into public-facing occupations such as healthcare, education, transportation, emergency response, and government service, where continued infectious exposure remains common. Collectively, these experiences create a cumulative exposure profile that differs meaningfully from civilian populations and justifies a military-specific prevalence correction.
Rather than treating these exposures as isolated variables, US-CCUC Military™ conceptualizes them as stacking factors that may influence susceptibility, recovery, and long-term disease recognition. This systems-based perspective aligns with established principles in military preventive medicine, where cumulative operational exposures are routinely evaluated when assessing force health protection and readiness (Schawaller et al., 2021; Allman et al., 2026).
Published Military Surveillance Gradient
Current military and veteran literature illustrates a consistent surveillance gradient.
Published Long COVID Surveillance Methods in Veteran Populations
Study | Population | Surveillance Method | Estimated Prevalence | Interpretation |
Elfessi et al., 2025 | 3,286 | Dedicated Long COVID clinic | 0.6% | Specialty care captures only the most visible cases |
Wander et al., 2023 | 388,980 | ICD-10 U09.9 diagnosis | 5.28% | Administrative documentation underestimates population burden due to coding variability |
Stephens et al., 2024 | 363,825 | Symptom-defined PASC | 45% | Persistent symptoms identify substantially larger populations than diagnosis codes alone |
Rather than representing conflicting science, these studies define the lower, middle, and upper observational boundaries of disease visibility. Specialty clinics measure healthcare penetration. Administrative coding measures recognized disease. Symptom surveillance measures clinical burden. US-CCUC Military™ integrates these complementary evidence streams to estimate the population most likely living with Long COVID rather than only those who have received formal documentation.
Worked Calculation
The corrected prevalence estimate begins with the current U.S. veteran population.
Inputs
Parameter | Value | Source |
U.S. Veteran Population (2026) | 16.96 million | U.S. Bureau of Labor Statistics (2026) |
Administrative Long COVID Documentation | 5.28% | Wander et al. (2023) |
Symptom-Based PASC Observation | 45% | Stephens et al. (2024) |
Specialty Clinic Observation | 0.6% | Elfessi et al. (2025) |
Rather than adopting any single published percentage, US-CCUC Military™ models a corrected planning range that reflects the convergence of published surveillance methods while accounting for documented underrecognition within diagnosis-based systems.
US-CCUC Military™ Planning Formula
Estimated Veterans with Long COVID = U.S. Veteran Population × Corrected Planning Rate
Using a corrected planning prevalence of 20.6% to 31.2%:
Lower Bound
16.96 million × 20.6%
= 3.49 million veterans
Upper Bound
16.96 million × 31.2%
= 5.29 million veterans
Rounded:
US-CCUC Military™ Estimate: 3.5 to 5.3 million U.S. veterans living with Long COVID
US-CCUC Military™ National Planning Estimate
This corrected estimate lies between administrative documentation and symptom-defined observational ceilings, reflecting a planning population rather than a simple extrapolation from any single study.
Population Estimate | Veterans |
Specialty Clinic Visibility | ~102,000 |
Administrative U09.9 Documentation | ~896,000 |
US-CCUC Military™ 2026 Corrected Estimate | 3.5–5.3 million |
Symptom-Based Upper Observation | ~7.63 million |
The corrected estimate remains robust across reasonable changes in planning assumptions.
Sensitivity Analysis
Corrected Prevalence | Estimated Veterans |
18% | 3.05 million |
20% | 3.39 million |
20.6% | 3.49 million |
25% | 4.24 million |
28% | 4.75 million |
31.2% | 5.29 million |
35% | 5.94 million |
This analysis demonstrates that relatively small changes in prevalence assumptions correspond to hundreds of thousands of additional veterans requiring healthcare services, disability evaluation, rehabilitation, and long-term follow-up. Consequently, accurate prevalence estimation represents a critical input for strategic planning rather than a purely academic exercise. The purpose of US-CCUC Military™ is therefore not to replace existing surveillance systems, but to complement them by estimating the broader population likely living with Long COVID beyond formal diagnostic documentation. As additional biomarker studies, wearable data, longitudinal cohorts, and Veterans Affairs surveillance initiatives mature, the framework can be iteratively refined while maintaining its central objective: correcting surveillance distortion to improve healthcare planning for America's veterans.
US-CCUC Military™ Demographic Visibility Adjustment (DVA)
US-CCUC Military™ Demographic Visibility Adjustment (DVA) is a demographic correction layer that adjusts military and veteran chronic condition estimates for differential diagnostic visibility, surveillance capture, healthcare utilization, and documented structural barriers to recognition across population subgroups. Rather than assuming observed diagnoses reflect true burden, DVA models the population most likely living with disease after correcting for diagnostic lag.
Veterans: US-CCUC Military™ DVA
Group | DVA Share | Low | High |
White non-Hispanic | 65.6% | 2.29M | 3.47M |
Black | 15.8% | 0.55M | 0.84M |
Latine/Hispanic | 10.7% | 0.38M | 0.57M |
Asian | 2.4% | 0.08M | 0.12M |
Indigenous/Native | 1.4% | 0.05M | 0.07M |
Multiracial/Other | 4.1% | 0.14M | 0.22M |
Based on 3.49M to 5.29M veterans living with Long COVID.
Active-Duty: US-CCUC Military™ DVA
Group | DVA Share | Low | High |
White non-Hispanic | 46.5% | 122K | 185K |
Black | 19.1% | 50K | 76K |
Latine/Hispanic | 21.8% | 57K | 87K |
Asian | 3.6% | 9K | 14K |
Indigenous/Native | 2.0% | 5K | 8K |
Multiracial/Other | 7.0% | 18K | 28 |
Using the same 20.6% to 31.2% corrected planning range on 1.273M active-duty members, the active-duty Long COVID planning estimate is approximately 262,000 to 397,000 service members.
6. Implications for Veteran Healthcare, Military Readiness, and Federal Planning
The implications of US-CCUC Military™ extend well beyond prevalence estimation. Population estimates form the foundation of healthcare planning, workforce forecasting, infrastructure investment, disability policy, clinical research, and federal appropriations. If the number of veterans living with Long COVID substantially exceeds current administrative surveillance, then many downstream planning assumptions may also underestimate future demand for services.
Within the Veterans Health Administration, prevalence estimates influence decisions regarding specialty clinic capacity, rehabilitation programs, workforce development, provider education, telehealth expansion, behavioral health services, and long-term resource allocation.
Administrative diagnosis alone provides an incomplete picture of future demand because many veterans continue to experience persistent fatigue, cognitive impairment, autonomic dysfunction, exercise intolerance, chronic pain, sleep disturbance, and multisystem symptoms without receiving formal Long COVID documentation. A planning population of 3.5 to 5.3 million veterans suggests that healthcare utilization may continue to expand even if administrative prevalence appears comparatively stable (Adinig, 2026).
The implications extend equally to disability evaluation and functional recovery. Long COVID frequently affects activities requiring sustained attention, executive function, memory, cardiovascular endurance, orthostatic tolerance, and post-exertional recovery. These limitations may influence employability, occupational performance, caregiver needs, and quality of life despite appearing relatively modest during routine clinical encounters (NASEM, 2024; Davis et al., 2023; Komaroff & Lipkin, 2023). More accurate prevalence estimates therefore strengthen long-term forecasting for disability systems while helping healthcare organizations anticipate future demand for multidisciplinary rehabilitation and supportive care.
Military readiness remains another important consideration. Although veterans comprise the primary focus of this analysis, active-duty military investigations demonstrate that persistent post-COVID symptoms can influence physical readiness, return-to-duty decisions, deployment capability, aviation medicine, and operational performance (Adams et al., 2021; Bova et al., 2025; Cintron et al., 2026). The convergence between active-duty symptom surveillance and veteran symptom-based investigations suggests that Long COVID should be viewed not only as a chronic health condition but also as an enduring readiness issue extending across the military lifecycle.
US-CCUC Military™ also has important implications for public health surveillance. Traditional administrative surveillance remains indispensable for monitoring diagnosed disease, evaluating healthcare utilization, and measuring clinical documentation. However, diagnosis codes alone cannot be assumed to represent the total population living with chronic post-infectious illness. Similar challenges have been recognized across numerous conditions in military medicine, where deployment screening, environmental surveillance, occupational monitoring, and preventive medicine programs routinely identify health risks extending beyond routine diagnostic encounters (Schawaller et al., 2021; Allman et al., 2026; Rubertone & Brundage, 2002).
The framework may likewise inform future clinical research. More accurate planning populations improve participant recruitment strategies, epidemiologic modeling, health economic analyses, biomarker studies, rehabilitation research, precision medicine initiatives, and clinical trial design. Underestimating prevalence risks underpowering research infrastructure, while overestimating prevalence may misdirect limited healthcare resources. Corrected national estimates provide a more stable foundation for both scientific investigation and strategic planning.
Finally, the implications extend beyond Long COVID itself. The principles underlying US-CCUC Military™ may be applicable to other infection-associated chronic conditions in which diagnosis-based surveillance systematically underrepresents the true population living with illness. Military populations have historically provided important insights into infectious disease epidemiology, preventive medicine, occupational health, and environmental exposure science. Extending surveillance correction methodologies to these conditions may strengthen future preparedness for both emerging infectious diseases and their long-term health consequences.
Potential Applications of US-CCUC Military™
Sector | Potential Application |
Veterans Health Administration | Healthcare capacity planning, specialty clinic development, rehabilitation services, workforce allocation |
Department of Defense | Force health protection, readiness surveillance, return-to-duty planning, operational health forecasting |
Federal Policymakers | Budget forecasting, disability planning, veteran health strategy, pandemic preparedness |
Clinical Research | Trial design, participant recruitment, epidemiology, biomarker discovery, longitudinal cohort development |
Public Health | Improved prevalence estimation, surveillance modernization, infection-associated chronic disease planning |
US-CCUC Military™ is intended as a planning framework rather than a replacement for existing surveillance systems. Its principal contribution is shifting national discussions from documented cases toward the estimated population living with Long COVID, allowing healthcare systems and policymakers to plan for the people who are likely already present rather than only those who have been formally recognized. As surveillance methods continue to evolve, integrating corrected population estimates with administrative reporting may provide a more complete understanding of Long COVID within the U.S. veteran community.
Future Application: Post-Influenza Chronic Illness and Military Readiness
The recent influenza outbreak at Joint Base San Antonio-Lackland, which sickened more than 200 Air Force trainees and was later reported as nearing 300 affected recruits, illustrates why military infectious disease planning cannot stop at acute containment (Air Force Times, 2026). Recruit training environments involve close quarters, physical stress, sleep disruption, rapid cohort turnover, and repeated respiratory exposure, all of which can amplify outbreak risk and disrupt readiness.
Although Long COVID remains the best-characterized modern post-viral condition, influenza and other infections have also been associated with prolonged symptoms and post-acute sequelae. Choutka et al. (2022) describe post-acute infection syndromes as persistent, disabling symptoms that can follow a range of common infections, not only SARS-CoV-2. CDC guidance similarly recognizes that infections may be followed by symptoms lasting weeks, months, or longer after the acute infectious period has resolved (CDC, 2024).
The term “Long Flu” has increasingly been used to describe prolonged health consequences after influenza infection, particularly among people hospitalized with flu. Al-Aly and colleagues reported that patients hospitalized with either COVID-19 or seasonal influenza experienced elevated risk of death, readmission, and multi-organ health outcomes over the 18 months following infection, with substantial risk persisting beyond the first 30 days after acute illness (Al-Aly et al., 2023).
For military populations, this matters because even a small post-influenza chronic illness fraction could become operationally meaningful when outbreaks occur in high-density training environments. US-CCUC Military™ is therefore not limited to Long COVID as a disease category. It offers a broader surveillance correction approach for estimating the hidden planning burden of post-infectious illness when specialty care, diagnosis codes, and symptom-defined studies measure different layers of disease visibility.
Future applications of US-CCUC Military™ should evaluate post-influenza symptom persistence, post-viral fatigue, dysautonomia-like symptoms, cognitive dysfunction, delayed return to physical performance, and downstream veteran healthcare utilization following major respiratory outbreaks. This would allow military and veteran health systems to move beyond acute outbreak counts and begin estimating long-term readiness, rehabilitation, disability, and healthcare capacity needs.
7. Economic and Strategic Implications
Corrected prevalence estimates become meaningful only when translated into healthcare utilization, workforce planning, and economic impact. While surveillance studies typically focus on estimating the number of individuals affected by Long COVID, healthcare systems ultimately plan around anticipated demand for clinical services, workforce capacity, disability programs, and long-term expenditures. The US-CCUC Military™ estimate of approximately 3.5 to 5.3 million U.S. veterans living with Long COVID therefore represents not only an epidemiologic finding but also a planning framework for the Veterans Health Administration (VHA).
Healthcare Utilization
Evidence from the Veterans Health Administration demonstrates that veterans recovering from COVID-19 continue to require substantially greater healthcare utilization than comparable veterans without prior infection. In a national VHA cohort, COVID-19 survivors averaged 5.12 additional outpatient visits per person during follow-up compared with matched controls (Bui et al., 2025). Although this estimate includes all post-COVID healthcare rather than only diagnosed Long COVID, it provides a conservative utilization anchor for federal healthcare planning.
Applying this utilization estimate to the corrected US-CCUC Military™ prevalence produces the following annual outpatient demand.
Estimated Annual Excess Outpatient Visits
Estimated Veterans with Long COVID | Formula | Estimated Additional Annual Visits |
3.5 million | 3.5M × 5.12 | 17.9 million |
5.3 million | 5.3M × 5.12 | 27.1 million |
These estimates represent excess outpatient encounters above expected healthcare utilization and likely underestimate total demand because many veterans with Long COVID require multidisciplinary management across primary care, cardiology, pulmonology, neurology, rehabilitation medicine, behavioral health, and specialty referral services.
Specialty Long COVID Care
The Veterans Health Administration has established multidisciplinary Long COVID Clinics; however, current utilization remains limited. Among approximately 495,000 veterans with documented SARS-CoV-2 infection, 5.9% received an ICD-10 diagnosis of Long COVID (U09.9), while only 2.0% attended at least one dedicated Long COVID Clinic. Even among veterans with documented Long COVID, only 17.4% received care through a Long COVID Clinic, suggesting that most veterans continue to receive care through traditional specialty services rather than dedicated multidisciplinary programs (Bui et al., 2025). Applying these utilization patterns to the corrected prevalence estimates illustrates the scale of potential unmet specialty care demand.
Projected Long COVID Clinic Demand
Scenario | 3.5 Million Veterans | 5.3 Million Veterans |
Current clinic utilization (2%) | 70,000 | 106,000 |
If utilization matched documented Long COVID patients (17.4%) | 609,000 | 922,000 |
One comprehensive multidisciplinary evaluation for every veteran with Long COVID | 3.5 million | 5.3 million |
These projections suggest that current specialty clinic utilization captures only a small proportion of the veteran population projected by US-CCUC Military™, emphasizing the importance of planning beyond dedicated Long COVID clinics alone.
Annual Economic Impact
While direct healthcare expenditures represent an important component of Long COVID, they capture only part of the condition's overall economic impact. Previous CYNAERA economic modeling estimated approximately $4,000 per patient per year in direct care inefficiency associated with delayed diagnosis, fragmented care, repeated healthcare utilization, prolonged treatment pathways, and reduced healthcare system efficiency (Adinig, 2026). Separately, the Organization for Economic Co-operation and Development (OECD) estimated that approximately 20% of individuals living with Long COVID experience meaningful employment disruption, resulting in reduced productivity, workforce participation, absenteeism, presenteeism, and diminished labour input (OECD, 2026). Using these conservative assumptions, the US-CCUC Military™ prevalence estimate suggests that Long COVID may represent approximately $20 billion to $30 billion annually in combined direct care inefficiency and workforce-related economic impact among U.S. veterans.
Estimated Annual Economic Impact of Long COVID in U.S. Veterans
Component | Lower Estimate | Upper Estimate |
Direct care inefficiency | $14.0 billion | $21.2 billion |
Workforce-related economic impact | $5.6 billion | $8.5 billion |
Estimated Annual Economic Impact | $19.6 billion | $29.7 billion |
These estimates should be interpreted as conservative planning values rather than comprehensive national cost estimates. They do not include Veterans Affairs disability compensation, Social Security Disability Insurance, military retirement benefits, caregiver burden, housing instability, pharmaceutical expenditures outside modeled healthcare utilization, or broader downstream societal costs. Consequently, the true economic impact of Long COVID among U.S. veterans is likely substantially greater than these estimates suggest.
Estimated Five-Year Excess Direct Healthcare Costs
Long COVID is increasingly recognized as a chronic condition associated with sustained healthcare expenditures. A recent longitudinal analysis of more than 143,000 adults followed over five years found that healthcare costs associated with Long COVID increased progressively rather than declining over time. Individuals with Long COVID demonstrated 20% higher odds of healthcare utilization, 30% higher healthcare costs when healthcare was accessed, and accumulated an estimated $7,124 in excess direct healthcare costs over five years compared with individuals without Long COVID (Cheng et al., 2026 preprint). Applying these published excess cost estimates to the corrected veteran prevalence estimates provides an estimate of cumulative direct healthcare expenditures.
5 Year Excess Direct Healthcare Costs
Estimated Veterans with Long COVID | Formula | 5 Year Excess Healthcare Costs |
3.5 million | 3.5M × $7,124 | $24.9 billion |
5.3 million | 5.3M × $7,124 | $37.8 billion |
These estimates reflect excess direct healthcare expenditures only and do not include disability compensation, pharmacy costs outside captured healthcare systems, long-term caregiving, reduced workforce participation, or broader societal costs.
Workforce and Economic Impact
The consequences of Long COVID extend well beyond healthcare utilization. The Organization for Economic Co-operation and Development (OECD) concluded that indirect economic costs associated with Long COVID are likely to exceed direct healthcare expenditures over the coming decade. Long COVID has been associated with employment disruption in approximately one in five affected workers, corresponding to an estimated 5–10% reduction in labour input during the first year after infection. Under conservative assumptions, the OECD projects persistent annual economic losses equivalent to 0.1–0.2% of gross domestic product, highlighting the long-term macroeconomic implications of persistent post-COVID illness (OECD, 2026). Applying these workforce estimates to the corrected US-CCUC Military™ prevalence suggests that substantial numbers of veterans may experience ongoing employment limitations.
Estimated Workforce Impact
Planning Metric | 3.5 Million Veterans | 5.3 Million Veterans |
Veterans potentially experiencing employment disruption (20%) | 700,000 | 1.06 million |
Veterans requiring ongoing longitudinal medical follow-up | 3.5 million | 5.3 million |
Veterans potentially requiring coordinated multidisciplinary care | 3.5 million | 5.3 million |
Although not all affected veterans remain in the civilian workforce, these projections underscore the potential downstream effects of Long COVID on disability compensation, caregiver burden, workforce participation, military readiness, and long-term federal planning.
Implications for Veterans Health Administration Planning
The central contribution of US-CCUC Military™ is not simply a revised prevalence estimate but a revised planning framework. Under corrected prevalence estimates, Long COVID among U.S. veterans may translate into 17.9 to 27.1 million additional outpatient healthcare encounters annually, approximately $20 billion to $30 billion in annual direct care inefficiency and workforce-related economic impact, $24.9 to $37.8 billion in cumulative excess direct healthcare expenditures over five years, and 700,000 to more than one million veterans experiencing employment disruption. These projections reinforce the importance of integrating corrected prevalence estimates into Veterans Health Administration workforce planning, multidisciplinary care models, rehabilitation services, disability forecasting, and future federal resource allocation.
Accurate prevalence estimation therefore represents more than an epidemiologic exercise. It serves as a foundational input for healthcare infrastructure planning, military medicine, veteran disability policy, economic forecasting, and long-term public health preparedness.
8. Limitations
Like all population estimation frameworks, US-CCUC Military™ should be interpreted within the context of its underlying assumptions and available evidence. The framework is designed to estimate the most plausible national planning population rather than provide an exact census of every veteran living with Long COVID. As additional epidemiologic data become available, future refinements may improve the precision of these estimates while preserving the core principles of surveillance correction. First, the framework integrates evidence generated from multiple surveillance methodologies that were developed for different research objectives. Administrative diagnosis studies, specialty clinic cohorts, symptom-based investigations, predictive modeling studies, and military surveillance reports each capture distinct aspects of the veteran Long COVID population. Rather than treating these investigations as competing estimates, US-CCUC Military™ synthesizes them into a unified planning framework. Future studies using standardized case definitions across military and veteran populations will allow more direct comparisons between surveillance approaches (WHO, 2021; CDC, 2024; NASEM, 2024).
Second, military and veteran populations are heterogeneous. Active-duty personnel, Reserve and National Guard members, recently separated veterans, aging veterans, combat veterans, and veterans with different occupational specialties may experience substantially different exposure histories, healthcare utilization patterns, and Long COVID trajectories. US-CCUC Military™ provides a national estimate for the overall veteran population rather than branch-specific or occupation-specific prevalence estimates. Future analyses may identify important differences across service branches, deployment histories, military occupations, geographic regions, or demographic groups.
Third, Long COVID remains an evolving clinical condition. Diagnostic criteria, healthcare utilization, clinician awareness, rehabilitation services, and coding practices continue to change as scientific understanding advances. Administrative prevalence should therefore be expected to evolve over time independent of changes in the underlying population living with illness. The framework is intended to remain adaptable as surveillance systems mature and new evidence becomes available. Fourth, the current framework estimates prevalence rather than disease severity. Veterans living with Long COVID represent a clinically heterogeneous population ranging from individuals with relatively mild functional limitations to those experiencing severe multisystem impairment. US-CCUC Military™ estimates the overall planning population but does not stratify veterans according to symptom severity, functional status, healthcare utilization, disability level, or recovery trajectory. These dimensions represent important opportunities for future refinement.
Finally, US-CCUC Military™ should be viewed as a complement to existing surveillance systems rather than a replacement for administrative reporting. Diagnosis codes, specialty clinics, electronic health records, wearable technologies, patient-reported outcomes, and longitudinal cohort studies each contribute valuable information regarding the evolving epidemiology of Long COVID. Integrating these complementary evidence streams may ultimately provide the most complete understanding of persistent post-COVID illness within military and veteran populations.
Recognizing these limitations does not diminish the central contribution of this framework. Instead, it reflects the reality that prevalence estimation is an iterative process. As new evidence emerges, corrected population models should evolve alongside advances in military medicine, epidemiology, and infection-associated chronic disease research.
9. Future Research Priorities: Building the Next Generation of Military Long COVID Intelligence
US-CCUC Military™ is intended to represent the first stage of a broader military intelligence framework for infection-associated chronic conditions. Correcting national prevalence is an essential starting point because healthcare systems cannot effectively plan for populations that remain incompletely counted. However, prevalence alone does not explain why some service members recover rapidly while others develop persistent multisystem illness, nor does it identify which interventions are most likely to improve long-term outcomes. Future military research should therefore move beyond counting cases toward understanding risk, recognition, recovery, and prevention.
PCT Military™: Identifying Preventable Trigger Patterns
One of the next priorities should be adapting the Primary Chronic Trigger (PCT™) framework to military and veteran populations. Military service presents a unique convergence of biological and environmental exposures rarely encountered within civilian populations, including repeated respiratory infections, international deployments, environmental particulate exposure, changing climates, altered nutrition, disrupted sleep, operational stress, vaccination programs, occupational hazards, and intensive physical demands. Rather than examining these variables independently, PCT Military™ would evaluate how combinations of exposures influence the likelihood of developing persistent post-infectious illness.
This systems-based approach may help identify modifiable trigger patterns before chronic illness becomes established. Rather than asking whether a single exposure causes Long COVID, PCT Military™ asks whether cumulative exposure profiles alter biological resilience and influence recovery following SARS-CoV-2 infection. Such an approach may improve future prevention strategies while informing deployment medicine, rehabilitation planning, occupational health, and force protection.
CDF-LC ™: A Diagnostic Fingerprint for Earlier Recognition
Accurate prevalence estimation represents only one component of effective surveillance. Earlier recognition remains equally important. Current evidence suggests that many veterans experience persistent fatigue, autonomic dysfunction, cognitive impairment, sleep disturbance, cardiopulmonary symptoms, gastrointestinal dysfunction, pain, and exercise intolerance without receiving a formal Long COVID diagnosis. These patients frequently move between specialties while individual symptoms are evaluated independently rather than recognized as components of a broader post-infectious syndrome (Stephens et al., 2024; Wander et al., 2023; NASEM, 2024).
The Long COVID Composite Diagnostic Fingerprint (CDF-LC™) represents a potential next step toward improving diagnostic recognition. Rather than relying upon any single biomarker or symptom, the framework would evaluate combinations of clinical features, healthcare utilization patterns, laboratory findings, autonomic measures, environmental factors, and patient-reported outcomes to identify veterans whose overall clinical profile is consistent with Long COVID despite fragmented documentation. Such an approach could improve surveillance while supporting earlier referral, multidisciplinary evaluation, rehabilitation, and clinical trial enrollment.
Precision Surveillance for Military Medicine
Military medicine is uniquely positioned to lead the next generation of precision surveillance. The integration of longitudinal electronic health records, Defense Medical Surveillance System data, Veterans Health Administration records, deployment histories, environmental monitoring, wearable technologies, rehabilitation outcomes, and patient-reported symptom trajectories creates opportunities unavailable in most civilian healthcare systems. Future investigations may combine these resources to develop dynamic surveillance systems capable of identifying persistent illness before traditional diagnosis-based methods. Such efforts could also improve understanding of recovery trajectories rather than focusing exclusively on disease onset.
Longitudinal analyses examining symptom fluctuation, remission, reinfection, environmental influences, occupational exposures, rehabilitation strategies, and biological markers may ultimately prove as important as prevalence itself. Understanding why veterans recover may become as valuable as understanding why they become ill.
Toward an Integrated Military Intelligence Framework
Together, US-CCUC Military™, PCT Military™, and CDF-LC represent complementary components of a broader systems approach to infection-associated chronic conditions.
US-CCUC Military™ estimates the true national population living with Long COVID.
PCT Military™ investigates the cumulative biological and environmental factors that influence persistent illness.
CDF-LC ™ improves earlier recognition through multidimensional diagnostic pattern analysis.
Rather than functioning as independent tools, these frameworks are designed to operate sequentially. First, accurately estimate the affected population. Second, identify the biological and environmental conditions associated with persistent illness. Third, improve recognition so that veterans receive earlier evaluation, appropriate care, and access to emerging therapies.
As military medicine continues to evolve from reactive healthcare toward predictive population health, integrated surveillance frameworks may become increasingly important for Long COVID and other infection-associated chronic conditions. By combining corrected prevalence estimation, trigger analysis, and precision diagnostic recognition, CYNAERA envisions a future in which military health systems move beyond simply documenting chronic illness toward anticipating, recognizing, and ultimately reducing its long-term impact.
10. Conclusion
Long COVID has fundamentally changed the landscape of military and veteran healthcare. More than six years after the emergence of SARS-CoV-2, substantial progress has been made in characterizing the biological complexity of persistent post-COVID illness, yet one of the most basic public health questions remains incompletely answered: How many veterans are actually living with Long COVID? The evidence reviewed throughout this paper suggests that the apparent disagreement within the literature is not primarily a disagreement about disease. Rather, it reflects differences in surveillance methodology. Specialty Long COVID clinics identify a relatively small population receiving dedicated care. Administrative diagnosis codes capture veterans who have been formally recognized within healthcare systems. Symptom-based investigations identify a substantially larger population whose illness becomes visible when persistent symptoms, rather than diagnostic labels alone, are used as the foundation for surveillance. These approaches should not be viewed as competing estimates. They represent different levels of visibility within the same underlying population.
US-CCUC Military™ was developed to bridge this surveillance gap. Building upon CYNAERA's U.S. Chronic Condition Undercount Correction (US-CCUC™) framework, the model integrates published epidemiology, military health surveillance, symptom-based investigations, and veteran-specific exposure characteristics to generate a corrected national planning estimate. Using this approach, US-CCUC Military™ estimates that approximately 3.5 to 5.3 million U.S. veterans are currently living with Long COVID, substantially exceeding the population represented by diagnosis codes alone while remaining grounded in the broader symptom-based literature.
The significance of this estimate extends well beyond epidemiology. Population estimates influence healthcare infrastructure, disability planning, workforce forecasting, rehabilitation capacity, caregiver support, research investment, and federal resource allocation. Every planning decision begins with an assumption about how many people require care. When that assumption underestimates the true population, downstream systems may also underestimate future demand.
This paper also argues that military medicine provides an ideal environment for advancing the next generation of infection-associated chronic disease research. Decades of investment in preventive medicine, longitudinal surveillance, occupational health, deployment medicine, and environmental monitoring have created one of the world's most sophisticated population health ecosystems. Rather than introducing an entirely new philosophy, US-CCUC Military™ extends principles already embedded within military health surveillance by integrating multiple evidence streams into a more comprehensive estimate of persistent illness.
Corrected prevalence, however, represents only the beginning. Future progress will require complementary advances in risk stratification, diagnostic recognition, environmental health, biomarker discovery, rehabilitation science, and precision surveillance. CYNAERA's broader military framework, including US-CCUC Military™, PCT Military™, and CDF-LC Military™, is intended to support that evolution by moving beyond isolated diagnoses toward integrated intelligence capable of improving prevention, recognition, planning, and ultimately patient outcomes. Long COVID is likely to remain a defining challenge for military and veteran healthcare for years to come. Meeting that challenge begins with accurately recognizing the population already living with the condition. Better surveillance produces better estimates. Better estimates support better planning. Better planning creates the opportunity for better outcomes. In that sense, correcting prevalence is not simply an epidemiologic exercise. It is the foundation upon which future military health policy, clinical research, and veteran care can be built.
Frequently Asked Questions
How many U.S. veterans may be living with Long COVID?
US-CCUC Military™ estimates that approximately 3.5 to 5.3 million U.S. veterans may be living with Long COVID. This corrected national estimate is higher than diagnosis-code counts because many veterans with persistent post-COVID symptoms are not formally documented with ICD-10 code U09.9.
What is the estimated prevalence of Long COVID in U.S. military and veteran populations?
The corrected US-CCUC Military™ planning estimate corresponds to approximately 20.6% to 31.2% of the current U.S. veteran population. This range is positioned between administrative diagnosis rates and symptom-based studies that identify much larger post-COVID populations.
Why are official Long COVID counts in veterans likely too low?
Official counts are likely too low because they depend heavily on diagnostic coding, clinic access, provider recognition, and healthcare documentation. Veterans may have fatigue, brain fog, shortness of breath, dysautonomia, sleep disruption, pain, or post-exertional symptom worsening without receiving a formal Long COVID diagnosis.
Why do Long COVID estimates vary so much in veteran studies?
Long COVID estimates vary because studies use different surveillance methods. Specialty clinic studies capture the smallest and most visible group, ICD-10 code studies capture formally documented cases, and symptom-based studies capture a much larger population experiencing persistent post-COVID symptoms.
What is US-CCUC Military™?
US-CCUC Military™ is a CYNAERA prevalence correction methodology designed to estimate the real-world number of U.S. veterans living with Long COVID. It integrates administrative data, symptom-based surveillance, military exposure patterns, and undercount correction logic to produce a corrected national planning estimate.
Is US-CCUC Military™ a diagnostic tool?
No. US-CCUC Military™ is not a clinical diagnostic tool. It is a population health and healthcare planning framework intended to estimate how many veterans may be living with Long COVID at the national level.
Does this paper claim every veteran with Long COVID needs specialty care?
No. Long COVID exists across a spectrum. Some veterans may need primary care monitoring, while others require cardiology, pulmonology, neurology, rehabilitation medicine, behavioral health, autonomic evaluation, or multidisciplinary Long COVID care.
What does Long COVID mean for Veterans Health Administration planning?
Long COVID may create substantial demand for primary care, specialty referrals, rehabilitation, behavioral health, disability evaluation, and long-term follow-up. Using corrected prevalence estimates, this paper projects 17.9 to 27.1 million additional outpatient visits among U.S. veterans.
What is the projected healthcare cost of Long COVID in U.S. veterans?
Under corrected prevalence estimates, Long COVID among U.S. veterans translate into 17.9 to 27.1 million additional outpatient healthcare encounters annually, approximately $20 billion to $30 billion in annual direct care inefficiency and workforce-related economic impact, $24.9 to $37.8 billion in cumulative excess direct healthcare expenditures over five years, and 700,000 to more than one million veterans experiencing employment disruption.
How could Long COVID affect veteran employment?
Long COVID may affect veteran employment through fatigue, cognitive dysfunction, post-exertional symptom worsening, dysautonomia, pain, and reduced stamina. Applying OECD employment disruption estimates suggests that approximately 700,000 to 1.06 million veterans may experience employment disruption related to Long COVID.
Why does Long COVID matter for military readiness?
Long COVID matters for military readiness because persistent symptoms can affect physical performance, cognitive function, return to duty decisions, deployability, rehabilitation needs, and reserve or veteran workforce capacity. Military and veteran populations should be modeled as high-exposure, high-stacking populations rather than average-risk civilian populations.
What is the main policy implication of this paper?
The main policy implication is that federal planning based only on documented Long COVID diagnoses may substantially underestimate healthcare demand among veterans. Corrected prevalence estimates should inform Veterans Health Administration planning, disability forecasting, rehabilitation capacity, research funding, and military health strategy.
Licensing and Enterprise Positioning
US-CCUC Military™ extends the broader US-CCUC™ architecture into military and veteran health by providing a modular intelligence framework for surveillance correction, prevalence estimation, healthcare forecasting, disability planning, and readiness assessment. The framework is designed for integration across federal agencies, veteran health systems, research institutions, clinical trial design, and public health surveillance initiatives seeking more accurate estimates of infection-associated chronic disease burden.
CYNAERA Framework Papers
This paper draws on a defined subset of CYNAERA Institute white papers that establish the methodological and analytical foundations of CYNAERA’s frameworks. These publications provide deeper context on prevalence reconstruction, remission, combination therapies and biomarker approaches. Our Long COVID Library, ME/CFS Library, Lyme Library, Autoimmune Library and CRISPR Remission Library are also in depth resources.
Author’s Note:
All insights, frameworks, and recommendations in this written material reflect the author's independent analysis and synthesis. References to researchers, clinicians, and advocacy organizations acknowledge their contributions to the field but do not imply endorsement of the specific frameworks, conclusions, or policy models proposed herein. This information is not medical guidance.
Patent-Pending Systems
Bioadaptive Systems Therapeutics™ (BST) and affiliated CYNAERA frameworks are protected under U.S. Provisional Patent Application No. 63/909,951. CYNAERA is built as modular intelligence infrastructure designed for licensing, integration, and strategic deployment across health, research, public sector, and enterprise environments.
Licensing and Integration
CYNAERA supports licensing of individual modules, bundled systems, and broader architecture layers. Current applications include research modernization, trial stabilization, diagnostic innovation, environmental forecasting, and population level modeling for complex chronic conditions. Basic licensing is available through CYNAERA Market, with additional pathways for pilot programs, institutional partnerships, and enterprise integration.
About the Author
Cynthia Adinig is the founder of CYNAERA, a modular intelligence infrastructure company that transforms fragmented real world data into predictive insight across healthcare, climate, and public sector risk environments. Her work sits at the intersection of AI infrastructure, federal policy, and complex health system modeling, with a focus on helping institutions detect hidden costs, anticipate service demand, and strengthen planning in high uncertainty environments.
Cynthia has contributed to federal health and data modernization efforts spanning HHS, NIH, CDC, FDA, AHRQ, and NASEM, and has worked with congressional offices including Senator Tim Kaine, Senator Ed Markey, Representative Don Beyer, and Representative Jack Bergman on legislative initiatives related to chronic illness surveillance, healthcare access, and data infrastructure. In 2025, she was appointed to advise the U.S. Department of Health and Human Services and has testified before Congress on healthcare data gaps and system level risk.
She is a PCORI Merit Reviewer, currently advises Selin Lab at UMass Chan, and has co-authored research with Harlan Krumholz, MD, Akiko Iwasaki, PhD, and David Putrino, PhD, including through Yale’s LISTEN Study. She also advised Amy Proal, PhD’s research group at Mount Sinai through its CoRE advisory board and has worked with Dr. Peter Rowe of Johns Hopkins on national education and outreach focused on post-viral and autonomic illness. Her CRISPR Remission™ abstract was presented at CRISPRMED26 and she has authored a Milken Institute essay on artificial intelligence and healthcare.
Cynthia has been covered by outlets including TIME, Bloomberg, Fortune, and USA Today for her policy, advocacy, and public health work. Her perspective on complex chronic conditions is also informed by lived experience, which sharpened her commitment to reforming how chronic illness is understood, studied, and treated. She also advocates for domestic violence prevention and patient safety, bringing a trauma informed lens to her research, systems design, and policy work. Based in Northern Virginia, she brings more than a decade of experience in strategy, narrative design, and systems thinking to the development of cross sector intelligence infrastructure designed to reduce uncertainty, improve resilience, and support institutional decision making at scale.
References
Adams, J., et al. (2021). Long COVID and implications for military medicine. Military Medicine.
Adinig, C. (2026). US-CCUC: Correcting Surveillance-Based Prevalence Undercounting Across Infection-Associated Chronic Conditions. SSRN.
Air Force Times. (2026). Flu outbreak sickens more than 200 trainees at Lackland Air Force Base. Air Force Times.
Al-Aly, Z., Bowe, B. and Xie, Y. (2022). Long COVID after breakthrough SARS-CoV-2 infection. Nature Medicine, 28, 1461-1467.
Al-Aly, Z., Bowe, B., Xie, Y., et al. (2024). Long-term health outcomes following COVID-19 compared with seasonal influenza: A cohort study. The Lancet Infectious Diseases.
Al-Aly, Z., Xie, Y. and Bowe, B. (2022). High-dimensional characterization of post-acute sequelae of COVID-19. Nature, 594, 259-264.
Allman, M.W.R., Marquez, A.R., Kotas, K.S. and Scatliffe-Carrion, K. (2026). Reportable Medical Events. Medical Surveillance Monthly Report. Defense Health Agency.
Armed Forces Health Surveillance Division. (2022). Armed Forces Reportable Medical Events Guidelines and Case Definitions. Defense Health Agency.
Armed Forces Health Surveillance Division. (2025). Medical Surveillance Monthly Report. Defense Health Agency.
Bova, A., et al. (2025). Strategies for Forecasting Long COVID in the Active Component Military Population. Defense Health Agency.
Brookings Institution. (2022). Long COVID and the American Workforce.
Centers for Disease Control and Prevention. (2024). About Chronic Symptoms Following Infections. U.S. Department of Health and Human Services.
Centers for Disease Control and Prevention. (2024). Clinical Overview of Long COVID.
Centers for Disease Control and Prevention. (2024). Long COVID.
Choutka, J., Jansari, V., Hornig, M. and Iwasaki, A. (2022). Unexplained post-acute infection syndromes. Nature Medicine, 28(5), 911-923.
Chretien, J.P., Gaydos, J.C., Malone, J.L., et al. (2007). Global infectious disease surveillance in the U.S. military. Military Medicine.
Cintron, M., et al. (2026). Prevalence and symptoms of post-COVID-19 syndrome in active-duty military personnel. Military Medicine.
Cutler, D.M. (2022). The Economic Cost of Long COVID. Harvard University.
Davis, H.E., Assaf, G.S., McCorkell, L., et al. (2021). Characterizing Long COVID in an international cohort: Seven months of symptoms and their impact. EClinicalMedicine, 38.
Davis, H.E., McCorkell, L., Vogel, J.M. and Topol, E.J. (2023). Long COVID: Major findings, mechanisms and recommendations. Nature Reviews Microbiology.
Defense Health Agency. (2025). Strategies for Forecasting Long COVID in the Active Component Military Population.
Department of Defense. (2026). Department of Defense reinstates influenza vaccination requirements following Joint Base San Antonio-Lackland outbreak. U.S. Department of Defense.
Department of Veterans Affairs. (2025). Veterans Health Administration Annual Report.
Elfessi, Z., Rubinstein, I., Gordon, H., Young, L., Beshalske, A., Gardner, J., et al. (2025). Long COVID prevalence in elderly, high-risk U.S. military veterans residing in inner-city Chicago prescribed nirmatrelvir/ritonavir. CHEST, 168(Suppl.).
Galea, S. and Keyes, K.M. (2019). Understanding population health through epidemiologic surveillance. Annual Review of Public Health.
Government Accountability Office. (2024). VA Health Care: Opportunities to Improve Access and Workforce Planning.
Gray, G.C., Callahan, J.D., Hawksworth, A.W., et al. (1999). Respiratory diseases among military personnel. Military Medicine.
Holick, M.F. (2007). Vitamin D deficiency. New England Journal of Medicine, 357, 266-281.
Hood, L. and Flores, M. (2012). A personal view on systems medicine and the emergence of proactive P4 medicine. New Biotechnology, 29(6), 613-624.
Institute of Medicine. (2008). Gulf War and Health: Volume 6. National Academies Press.
Jones, B.H. and Hauschild, V.D. (2015). Physical training, injury prevention and military readiness. Military Medicine.
Komaroff, A.L. and Lipkin, W.I. (2023). Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of Long COVID. Trends in Molecular Medicine.
Last, J.M. (Ed.). (2014). A Dictionary of Epidemiology (6th ed.). Oxford University Press.
Loscalzo, J. and Barabási, A.L. (2011). Systems biology and the future of medicine. Wiley Interdisciplinary Reviews: Systems Biology and Medicine.
National Academies of Sciences, Engineering, and Medicine. (2019). Strengthening the Military Health System.
National Academies of Sciences, Engineering, and Medicine. (2024). Long-Term Health Effects of COVID-19.
National Bureau of Economic Research. (2023). Long COVID and Labor Market Outcomes.
National Research Council. (2011). Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. National Academies Press.
Office of Management and Budget. (2025). Analytical Perspectives: Budget of the United States Government.
Peluso, M.J., Deeks, S.G., et al. (2023). Long COVID: Pathogenesis, clinical manifestations and treatment considerations. Nature Reviews Immunology.
Phetsouphanh, C., Darley, D.R., Wilson, D.B., et al. (2022). Immunological dysfunction persists for eight months following SARS-CoV-2 infection irrespective of initial disease severity. Nature Immunology, 23, 210-216.
Pilz, S., März, W., Cashman, K.D., et al. (2019). Rationale and plan for vitamin D food fortification. Frontiers in Endocrinology, 10.
Pludowski, P., Holick, M.F., Pilz, S., Wagner, C.L., Hollis, B.W., Grant, W.B., Shoenfeld, Y., Lerchbaum, E., Llewellyn, D.J., Kienreich, K. and Soni, M. (2013). Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality: A review of recent evidence. Autoimmunity Reviews, 12(10), 976-989.
Putrino, D., et al. (2023). Clinical care, rehabilitation and future directions for Long COVID.
RECOVER Initiative. (2024). Researching COVID to Enhance Recovery (RECOVER). National Institutes of Health.
Rothman, K.J., Greenland, S. and Lash, T.L. (2021). Modern Epidemiology (4th ed.). Wolters Kluwer.
Rubertone, M.V. and Brundage, J.F. (2002). The Defense Medical Surveillance System and the Department of Defense Serum Repository. American Journal of Public Health, 92(12), 1900-1904.
Schawaller, M., Wiemer, D., Hagen, R.M. and Frickmann, H. (2021). Infectious diseases in German military personnel after predominantly tropical deployments: A retrospective assessment over 13 years. BMJ Military Health, 167, 213-219.
Smith, B., Wong, C.A., Boyko, E.J., et al. (2008). The Millennium Cohort Study: Twenty-first century prospects for military and veteran health research. Military Medicine.
Stephens, K.A., et al. (2024). Symptom-defined post-acute sequelae of SARS-CoV-2 infection among U.S. veterans. Military Medicine.
Topol, E. (2019). Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again. Basic Books.
U.S. Bureau of Labor Statistics. (2026). Employment Situation of Veterans Summary.
U.S. Department of Veterans Affairs. (2025). Office of Research and Development Annual Report.
Wander, P.L., et al. (2023). Geographic variation in ICD-10 coding of Long COVID among U.S. veterans. JAMA Network Open.
Washington University School of Medicine in St. Louis. (2024). Long flu has emerged as a consequence similar to Long COVID-19. Washington University School of Medicine.
World Health Organization. (2021). A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus.
Xie, Y., Xu, E., Bowe, B. and Al-Aly, Z. (2022). Long-term cardiovascular outcomes of COVID-19. Nature Medicine.
Comments